Lajme nga Bota

CEO of BioNtech: Will need the new vaccine, can be achieved within 100 days

CEO of BioNtech: Will need the new vaccine, can be achieved within 100 days

BioNTech should be able to relatively adapt its coronavirus vaccine in response to the Omicron variant, and the coming weeks will show how urgently an improvement is needed, its CEO Ugur Sahin told Reuters Next today.

"I believe that in principle at some point we will need a new vaccine against this new variant. The question is how urgent it must be," Sahin said.

He reiterated that a relaunch of the product could be achieved within 100 days and said a vaccine upgrade was already underway.

"If third booster injections still prevent the disease at a rate of 85-90% we would have more time to adapt to a new vaccine," he said.

German BioNTech and Pfizer jointly produced one of the first vaccines against COVID-19, with over 2 billion doses already given to protect people worldwide.

There are concerns that vaccines may not work so well against the Omicron variant which appeared last month.

Sahin reaffirmed his view that the new variant could infect vaccinated people, but would likely prevent the need for hospital care.

"We anticipate that infected people who have been vaccinated will still be protected from serious diseases," Sahin added.

Tiranapost.al